Cargando…

Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations

Carbohydrate esters are significant in medicinal chemistry because of their efficacy for the synthesis of biologically active drugs. In the present study, methyl β-D-galactopyranoside (MGP) was treated with various acyl halides to produce 6-O-acyl MGP esters by direct acylation method with an excell...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Md R., Yasmin, Farhana, Dey, Sujan, Mahmud, Shafi, Saleh, Md A., Emran, Talha B., Hasan, Imtiaj, Rajia, Sultana, Ogawa, Yukiko, Fujii, Yuki, Yamada, Masao, Ozeki, Yasuhiro, Kawsar, Sarkar M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761875/
https://www.ncbi.nlm.nih.gov/pubmed/35037163
http://dx.doi.org/10.1007/s10719-021-10039-3
_version_ 1784633631764905984
author Amin, Md R.
Yasmin, Farhana
Dey, Sujan
Mahmud, Shafi
Saleh, Md A.
Emran, Talha B.
Hasan, Imtiaj
Rajia, Sultana
Ogawa, Yukiko
Fujii, Yuki
Yamada, Masao
Ozeki, Yasuhiro
Kawsar, Sarkar M. A.
author_facet Amin, Md R.
Yasmin, Farhana
Dey, Sujan
Mahmud, Shafi
Saleh, Md A.
Emran, Talha B.
Hasan, Imtiaj
Rajia, Sultana
Ogawa, Yukiko
Fujii, Yuki
Yamada, Masao
Ozeki, Yasuhiro
Kawsar, Sarkar M. A.
author_sort Amin, Md R.
collection PubMed
description Carbohydrate esters are significant in medicinal chemistry because of their efficacy for the synthesis of biologically active drugs. In the present study, methyl β-D-galactopyranoside (MGP) was treated with various acyl halides to produce 6-O-acyl MGP esters by direct acylation method with an excellent yield. To obtain newer products for antimicrobial assessment studies, the 6-O-MGP esters were further modified into 2,3,4-tri-O-acyl MGP esters containing a wide variety of functionalities in a single molecular framework. The chemical structures of the newly synthesized compounds were elucidated by analyzing their physicochemical, elemental, and spectroscopic data. In vitro antimicrobial testing against five bacteria and two fungi and the prediction of activity spectra for substances (PASS) revealed that these MGP estes have promising antifungal functionality compared to their antibacterial activities. The antimicrobial tests demonstrated that the compounds 3 and 10 were the most potent against Bacillus subtilis and Escherichia coli strains, with the minimum inhibitory concentration (MIC) values ranging from 0.352 ± 0.02 to 0.703 ± 0.01 mg/ml and minimum bactericidal concentration (MBC) values ranging from 0.704 ± 0.02 to 1.408 ± 0.04 mg/ml. Density functional theory (DFT) at the B3LYP/3-21G level of theory was employed to enumerate, frontier orbital energy, enthalpy, free energy, electronic energy, MEP, dipole moment which evaluated the effect of certain groups (aliphatic and aromatic) on drug properties. They discovered that all esters were more thermodynamically stable than the parent molecule. Molecular docking is performed using AutoDock Vina to determine the binding affinities and interactions between the MGP esters and the SARS-CoV-2 main protease. The modified esters strongly interact with the prime Cys145, His41, MET165, GLY143, THR26, and ASN142 residues. The MGP esters’ shape and ability to form multiple electrostatic and hydrogen bonds with the active site match other minor-groove binders’ binding modes. The molecular dynamics simulation validates the molecular docking results. The pharmacokinetic characterization of the optimized inhibitor demonstrates that these MGP esters appear to be safer inhibitors and a combination of in silico ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction and drug-likeness had promising results due to their improved kinetic properties. Structure activity relationships (SAR) study including in vitro and silico results revealed that the acyl chain, palmitoyl (C16) and 4-chlorobenzoyl (4.ClC(6)H(4)CO-) in combination with sugar were found the most potential activates against human and fungal pathogens. After all, our comprehensive computational and statistical analysis shows that these selected MGP esters can be used as potential inhibitors against the SARS-CoV-2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10719-021-10039-3.
format Online
Article
Text
id pubmed-8761875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-87618752022-01-18 Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations Amin, Md R. Yasmin, Farhana Dey, Sujan Mahmud, Shafi Saleh, Md A. Emran, Talha B. Hasan, Imtiaj Rajia, Sultana Ogawa, Yukiko Fujii, Yuki Yamada, Masao Ozeki, Yasuhiro Kawsar, Sarkar M. A. Glycoconj J Original Article Carbohydrate esters are significant in medicinal chemistry because of their efficacy for the synthesis of biologically active drugs. In the present study, methyl β-D-galactopyranoside (MGP) was treated with various acyl halides to produce 6-O-acyl MGP esters by direct acylation method with an excellent yield. To obtain newer products for antimicrobial assessment studies, the 6-O-MGP esters were further modified into 2,3,4-tri-O-acyl MGP esters containing a wide variety of functionalities in a single molecular framework. The chemical structures of the newly synthesized compounds were elucidated by analyzing their physicochemical, elemental, and spectroscopic data. In vitro antimicrobial testing against five bacteria and two fungi and the prediction of activity spectra for substances (PASS) revealed that these MGP estes have promising antifungal functionality compared to their antibacterial activities. The antimicrobial tests demonstrated that the compounds 3 and 10 were the most potent against Bacillus subtilis and Escherichia coli strains, with the minimum inhibitory concentration (MIC) values ranging from 0.352 ± 0.02 to 0.703 ± 0.01 mg/ml and minimum bactericidal concentration (MBC) values ranging from 0.704 ± 0.02 to 1.408 ± 0.04 mg/ml. Density functional theory (DFT) at the B3LYP/3-21G level of theory was employed to enumerate, frontier orbital energy, enthalpy, free energy, electronic energy, MEP, dipole moment which evaluated the effect of certain groups (aliphatic and aromatic) on drug properties. They discovered that all esters were more thermodynamically stable than the parent molecule. Molecular docking is performed using AutoDock Vina to determine the binding affinities and interactions between the MGP esters and the SARS-CoV-2 main protease. The modified esters strongly interact with the prime Cys145, His41, MET165, GLY143, THR26, and ASN142 residues. The MGP esters’ shape and ability to form multiple electrostatic and hydrogen bonds with the active site match other minor-groove binders’ binding modes. The molecular dynamics simulation validates the molecular docking results. The pharmacokinetic characterization of the optimized inhibitor demonstrates that these MGP esters appear to be safer inhibitors and a combination of in silico ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction and drug-likeness had promising results due to their improved kinetic properties. Structure activity relationships (SAR) study including in vitro and silico results revealed that the acyl chain, palmitoyl (C16) and 4-chlorobenzoyl (4.ClC(6)H(4)CO-) in combination with sugar were found the most potential activates against human and fungal pathogens. After all, our comprehensive computational and statistical analysis shows that these selected MGP esters can be used as potential inhibitors against the SARS-CoV-2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10719-021-10039-3. Springer US 2022-01-17 2022 /pmc/articles/PMC8761875/ /pubmed/35037163 http://dx.doi.org/10.1007/s10719-021-10039-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Amin, Md R.
Yasmin, Farhana
Dey, Sujan
Mahmud, Shafi
Saleh, Md A.
Emran, Talha B.
Hasan, Imtiaj
Rajia, Sultana
Ogawa, Yukiko
Fujii, Yuki
Yamada, Masao
Ozeki, Yasuhiro
Kawsar, Sarkar M. A.
Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title_full Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title_fullStr Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title_full_unstemmed Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title_short Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations
title_sort methyl β-d-galactopyranoside esters as potential inhibitors for sars-cov-2 protease enzyme: synthesis, antimicrobial, pass, molecular docking, molecular dynamics simulations and quantum computations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761875/
https://www.ncbi.nlm.nih.gov/pubmed/35037163
http://dx.doi.org/10.1007/s10719-021-10039-3
work_keys_str_mv AT aminmdr methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT yasminfarhana methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT deysujan methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT mahmudshafi methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT salehmda methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT emrantalhab methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT hasanimtiaj methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT rajiasultana methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT ogawayukiko methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT fujiiyuki methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT yamadamasao methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT ozekiyasuhiro methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations
AT kawsarsarkarma methylbdgalactopyranosideestersaspotentialinhibitorsforsarscov2proteaseenzymesynthesisantimicrobialpassmoleculardockingmoleculardynamicssimulationsandquantumcomputations